Author:
Nikfar Shekoufeh,Rahimi Roja,Rezaie Ali,Abdollahi Mohammad
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference52 articles.
1. Shen EH, Das KM. Current therapeutic recommendations: infliximab for ulcerative colitis. J Clin Gastroenterol. 2004;38:741–745. doi: 10.1097/01.mcg.0000140188.88275.65 .
2. Kucharzik T, Maaser C, Lügering A, et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis. 2006;12:1068–1083. doi: 10.1097/01.mib.0000235827.21778.d5 .
3. Rezaie A, Khalaj S, Shabihkhani M, et al. Study on the correlations among disease activity index and salivary transforming growth factor-β1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci. 2007;1095:305–314. doi: 10.1196/annals.1397.034 .
4. Rahimi R, Nikfar S, Abdollahi M. Meta analysis technique confirms the effectiveness of anti-TNFa in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit. 2007;13:PI13–PI18.
5. Rahimi R, Nikfar S, Abdollahi M. Do anti tumor necrosis factors induce response and remission in patients with acute refractory crohn’s disease? A meta-analysis of controlled clinical trials. Biomed Pharmacother. 2007;61:75–80. doi: 10.1016/j.biopha.2006.06.022 .
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献